GPCA covers the latest fund, investment and industry news across our markets in two newsletters: NewsWatch is a weekly round-up of key transactions across asset classes; the Global Tech Brief is a bi-weekly review of tech transactions and innovations with cross-border applications. Subscribe in the left-hand sidebar.

Access past editions of NewsWatch here.

Apis Partners To Exit South Africa’s Retail Capital to TymeBank

Apis Partners, through its fund Apis Growth Fund I, has agreed to exit its 11.7% stake in Retail Capital, a South Africa-based fintech that provides SME financing, to TymeBank, another Apis Partners portfolio company, for an undisclosed amount. Read More

Atalaya Capital Management and Partners for Growth Provide USD150m Credit Facility to UAE’s Tabby

Tabby, a UAE-based BNPL startup, secured a $150m credit facility from Atalaya Capital Management and existing lender Partners for Growth. The company raised a USD54m Series B extension in March led by Sequoia Capital and STV. Read More

Singularity Growth Opportunities and SWC Global Lead USD20m Series B for India’s WebEngage

Singularity Ventures, through its Growth Opportunities Fund, and SWC Global led a USD20m Series B for WebEngage, an India-based full-stack CRM platform, with participation from Unmaj Corporation, NB Ventures, Shashwat Nakrani (BharatPe) and Gopal Srinivasan (TVS Capital), and follow-on from India Quotient, Blume Ventures and Indian Angel Network’s IAN Fund. Read More

Sarmayacar and Shorooq Partners Lead USD11m Round for Pakistan’s OneLoad

Sarmayacar and Shorooq Partners led a USD11m round for OneLoad, a Pakistan-based  logistics and fintech platform serving micro-retailers and run by EP Systems. The Bill and Melinda Gates Foundation invested in OneLoad in November 2021, and IFC invested in 2020. Read More

Monashees and Andreessen Horowitz Lead USD10m Seed Round for NG.CASH

Monashees and Andreessen Horowitz (a16z) led a USD10m seed round for NG.CASH, a  Brazil-based digital money management platform targeting the Gen Z demographic, with participation from 17Sigma and Norte Ventures. Read More

Panlin Capital and Sany Foundation Lead USD40m Series E for China’s Suzhou Ribo Life Science

Suzhou Ribo Life Science, a China-based clinical-stage biotech with a focus on nucleic acid research,raised USD40m in the first tranche of a Series E led by Panlin Capital and Sany Foundation’s Trinity Innovation Fund, with participation from new investors. The startup raised a CNY673m (~USD95m) Series C in 2020 from China state-owned Capital Venture Investment Fund, Legend Capital, CICC Capital,… Read More

Atalaya Capital Management and Partners for Growth Provide USD150m Credit Facility to  UAE’s Tabby

Tabby, a UAE-based BNPL startup, secured a $150m credit facility from Atalaya Capital Management and existing lender Partners for Growth. The company raised a USD54m Series B extension in March led by Sequoia Capital and STV. Read More

Yunfeng Capital and Gaorong Capital Lead USD200m Series B for Sironax

Yunfeng Capital and Gaorong Capital led a USD200m Series B for Sironax, a China-based clinical-stage biotech with a focus on the treatment of age-related degenerative disease, with participation from MSA Capital, a subsidiary of Abu Dhabi Investment Authority (ADIA), CBC Group, Long River Investments, LSV Capital, Superstring Capital and Future Innovation Fund, and follow-on from Temasek, Invus, F-Prime Capital, Eight… Read More

Saudi Arabia’s PIF Commits USD300m to OIIM’s and Equitix’s Rakiza Infrastructure Fund

Saudi Arabia’s sovereign wealth fund PIF committed USD300m to Rakiza Infrastructure Fund, a private infrastructure fund co-managed by Oman Infrastructure Investment Management (OIIM) and Equitix Investment Management with a focus on renewables, power and water, social infrastructure, telecommunications and transport and logistics assets in Oman and Saudi Arabia. The fund reached a USD410m first close in April 2020 and is… Read More

Qiming Venture Partners Leads USD22m Series A+ for China’s GluBio Therapeutics

Qiming Venture Partners led a USD22m Series A extension round for GluBio Therapeutics, a US- and China-based biotech focused on developing targeted protein degradation (TPD) drugs, with follow-on from Lilly Asia Ventures and Kaitai Capital. Read More

Insignia Venture Partners Reaches USD516m Final Close for Early-stage Venture Fund

Insignia Ventures Partners reached a USD516m final close for its third venture fund. The vehicle invests in early-stage Southeast Asian startups.  Read More

Omnivore Exits India’s Eruvaka to Nutreco for a Reported USD40-50m

Omnivore Partners exited India-based agritech Eruvaka to Nutreco for a reported USD40-50m.Omnivore first invested in Eruvaka in its Series A in 2013, following on in its Series B in 2018. Nutreco has increased its stake in Eruvaka to 93.7% and plans to take full ownership in 2023. Read more here, here and h Read More